Acclinate and HCN Global Forge Partnership to Enhance Clinical Research for Latino Communities

Acclinate and HCN Global Collaborate for Health Equity

In a pioneering move aimed at enhancing clinical research access and representation for Hispanic and Latino communities, Acclinate and HCN Global have announced a strategic partnership that promises to reshape the landscape of multicultural health engagement. This partnership is not just about numbers; it embodies a strong commitment to fostering genuine trust and long-term engagement within historically underrepresented communities.

Bridging Gaps in Representation

The collaboration merges Acclinate's extensive NOWINCLUDED platform, boasting over 250,000 members, with HCN Global's networks, which include La Red Hispana, LatinEQUIS, and Melanin Thriving, collectively reaching an impressive 290,000 individuals. This amalgamation is set to empower pharmaceutical and public health partners to conduct measurable, predictive end-to-end clinical trial health engagement that becomes particularly relevant for the Hispanic and Latino populations.

Both organizations aim to conduct a comprehensive analysis of community engagement, utilizing Acclinate's patented Participation Probability Index (PPI). This index will allow stakeholders to track engagement levels, measure trust-building efforts, and predict clinical trial readiness among their combined networks, ensuring outreach is not only widespread but also effective and focused.

Strategic Planning and Authentic Engagement

Driven by shared values, the partnership between Acclinate and HCN Global is not only operational but also strategically planned for real-world impacts. As part of their strategic blueprint, HCN Global has become a licensed user of Acclinate's e-DICT™ platform, enhancing their digital capabilities and ensuring that life sciences and pharmaceutical sponsors can reliably engage with the communities they aim to serve.

Both CEOs underscored the significance of this partnership. Del Smith, CEO of Acclinate, emphasized that authentic community trust is crucial for true representation in clinical research. He stated, “By collaborating with HCN Global, we’re not just reaching Hispanic and Latino populations; we’re measuring engagement, predicting readiness, and understanding barriers to participation.” This strategic approach aims to shift the industry from performative measures to sustained, culturally relevant community engagement.

In parallel, Alison Rodden, CEO of HCN Global, pointed out the importance of ongoing relationship building with Hispanic and Latino communities—not merely as a campaign but as a steadfast commitment to address health disparities. She noted that through this partnership, they can leverage technology to provide valuable data that illustrates exactly how community trust manifests and what is required to convert that into increased clinical trial participation.

Enhancing Health Education and Trial Participation

Looking towards the future, Acclinate is set to create a dedicated space branded under HCN Global within their NOWINCLUDED platform. This initiative holds the promise of developing a culturally attuned digital hub for Spanish-language health education, inclusive community programming, and resources aimed at increasing trial participation readiness. By providing specialized content that resonates with the Hispanic audience, both organizations seek to extend their reach and make substantive contributions to community health.

This partnership aims to ensure clinical trial sponsors can effectively access, engage, and mobilize Black and Hispanic communities across over 35 therapeutic areas. By addressing the unique needs and barriers these populations face regarding health research, Acclinate and HCN Global are poised to lead the way in improving representation and trust in clinical trials.

Conclusion

In conclusion, the strategic alliance between Acclinate and HCN Global represents a crucial step towards not only enhancing clinical research participation among Hispanic and Latino communities but also ensuring that health initiatives are rooted in trust, transparency, and cultural relevance. It is a promising development that could lead to more equitable health outcomes in the future, challenging the existing paradigms in clinical research and community engagement.